Literature DB >> 26493695

The Prediction of Sonographic features and BRAF Mutation for Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: Reply.

Ning Qu1,2, Rong-liang Shi1,2, Ben Ma1,2, Yi Gao3,2, Yu Wang1,2, Qing-hai Ji4,5.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26493695     DOI： 10.1007/s00268-015-3285-0

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  16 in total

1.  BRAF mutation analysis of fine-needle aspiration biopsies of papillary thyroid carcinoma: impact on diagnosis and prognosis.

Authors:  Agnes Colanta; Oscar Lin; Laura Tafe; Ronald Ghossein; Khedoudja Nafa; Talia Mitchell; Marc Ladanyi; Maria Arcila
Journal:  Acta Cytol       Date:  2011-12-09       Impact factor: 2.319

2.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

3.  BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer.

Authors:  Martha A Zeiger; Eric B Schneider
Journal:  Ann Surg Oncol       Date:  2013-01       Impact factor: 5.344

4.  Diagnostic value of immunohistochemistry for the detection of the BRAF(V600E) mutation in papillary thyroid carcinoma: comparative analysis with three DNA-based assays.

Authors:  Marius I Ilie; Sandra Lassalle; Elodie Long-Mira; Christelle Bonnetaud; Olivier Bordone; Virginie Lespinet; Aude Lamy; Jean-Christophe Sabourin; Juliette Haudebourg; Catherine Butori; Nicolas Guevara; Isabelle Peyrottes; Jean-Louis Sadoul; Alexandre Bozec; José Santini; David Capper; Andreas von Deimling; Jean-François Emile; Véronique Hofman; Paul Hofman
Journal:  Thyroid       Date:  2014-03-06       Impact factor: 6.568

Review 5.  Clinical application of molecular testing of fine-needle aspiration specimens in thyroid nodules.

Authors:  Linwah Yip; Robert L Ferris
Journal:  Otolaryngol Clin North Am       Date:  2014-06-12       Impact factor: 3.346

6.  BRAF mutation analysis and sonography as adjuncts to fine-needle aspiration cytology of papillary thyroid carcinoma: their relationships and roles.

Authors:  Won-Jin Moon; Nami Choi; Jin Woo Choi; Suk Kyeong Kim; Tae Sook Hwang
Journal:  AJR Am J Roentgenol       Date:  2012-03       Impact factor: 3.959

7.  Preoperative prediction of central lymph node metastasis in thyroid papillary microcarcinoma using clinicopathologic and sonographic features.

Authors:  Kyung-Eun Kim; Eun-Kyung Kim; Jung Hyun Yoon; Kyung Hwa Han; Hee Jung Moon; Jin Young Kwak
Journal:  World J Surg       Date:  2013-02       Impact factor: 3.352

8.  Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.

Authors:  Yuri E Nikiforov; David L Steward; Toni M Robinson-Smith; Bryan R Haugen; Joshua P Klopper; Zhaowen Zhu; James A Fagin; Mercedes Falciglia; Katherine Weber; Marina N Nikiforova
Journal:  J Clin Endocrinol Metab       Date:  2009-03-24       Impact factor: 5.958

9.  BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer.

Authors:  Gina M Howell; Marina N Nikiforova; Sally E Carty; Michaele J Armstrong; Steven P Hodak; Michael T Stang; Kelly L McCoy; Yuri E Nikiforov; Linwah Yip
Journal:  Ann Surg Oncol       Date:  2012-09-01       Impact factor: 5.344

10.  Prediction Table and Nomogram as Tools for Diagnosis of Papillary Thyroid Carcinoma: Combined Analysis of Ultrasonography, Fine-Needle Aspiration Biopsy, and BRAF V600E Mutation.

Authors:  Seo Ki Kim; Jun Ho Lee; Jung-Woo Woo; Inhye Park; Jun-Ho Choe; Jung-Han Kim; Jee Soo Kim
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.